Comparison

AZ12601011 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 100 mg
Item no. HY-122856-100mg
CASRN 2748337-86-0
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
AZ12601011 is an orally active, selective TGFBR1 kinase inhibitor with an IC50 of 18 nM and a Kd of 2.9 nM. AZ12601011 inhibits phosphorylation of SMAD2 via selectively inhibiting ALK4, TGFBR1, and ALK7. AZ12601011 inhibits mammary tumor growth [1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
313.36
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 5 mg/mL (ultrasonic)
Manufacturers Target
TGF-β Receptor
Isoform
ALK4; ALK7
Pathway
TGF-beta/Smad
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close